Dergiler / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 2

Naples prognostic score, Prognostic Nutritional Index, and CONUT score in predicting implantable cardioverter-defibrillator therapy outcomes in HFrEF

Hasan Can Könte(İSTANBUL MEDİPOL ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-9321-5673
Ömer Alyan(ISTANBUL MEDIPOL UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-4354-0918
Dursun Aras(ISTANBUL MEDIPOL UNIVERSITY, SCHOOL OF MEDICINE)0000-0002-3871-9219
Sayfa
—
Yayın Tarihi
2026-03-10
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The relatively high negative predictive values suggest a screening/supportive role for NPS (and other nutritional scores) in the context of ICD management in patients with HFrEF.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: To evaluate the predictive value of the Naples prognostic score (NPS) and other nutritional indices for appropriate implantable cardioverter-defibrillator (ICD) therapy in primary prevention patients with heart failure with reduced ejection fraction (HFrEF).
📊
Temel Bulgular & Veri:Methods: This retrospective cohort study included 288 adult patients with HFrEF who underwent primary prevention ICD implantation and followed for at least six months.
💡
Sonuç & Katkı:The relatively high negative predictive values suggest a screening/supportive role for NPS (and other nutritional scores) in the context of ICD management in patients with HFrEF.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Heart failure · defibrillators · implantable

Abstract

Aims: To evaluate the predictive value of the Naples prognostic score (NPS) and other nutritional indices for appropriate implantable cardioverter-defibrillator (ICD) therapy in primary prevention patients with heart failure with reduced ejection fraction (HFrEF). Methods: This retrospective cohort study included 288 adult patients with HFrEF who underwent primary prevention ICD implantation and followed for at least six months. Data were retrospectively collected from electronic medical records. The NPS, PNI, and CONUT scores were calculated from baseline laboratory values obtained at the time of ICD implantation. The primary endpoint was the predictive performance of NPS for appropriate ICD therapy. Results: Patients with appropriate therapy (n=194) were younger (p=0.002), had lower BMI (p<0.001), hemoglobin (p=0.020), and ischemic cardiomyopathy prevalence (p=0.025). Left ventricular end-diastolic diameter (LVEDD) and left ventricular end-systolic diameter (p=0.002) were higher in recipients of appropriate ICD shocks. Nutritional scores showed better nutritional status in the appropriate therapy group: higher PNI (p<0.001), lower NPS (p=0.001) and lower CONUT (p=0.015). ROC analysis revealed similar and modest discriminatory capabilities for all nutrition assessment tools (AUCs from 0.587 to 0.630). Multivariable logistic regression identified low BMI (p=0.002), high LVEDD (p=0.007), and high albumin (p<0.001) as independent predictors of appropriate therapy. Conclusion: In primary prevention ICD recipients with HFrEF, appropriate therapy was linked to lower BMI, higher LVEDD, and elevated albumin, while nutritional indices showed univariate but not multivariable predictive value. The relatively high negative predictive values suggest a screening/supportive role for NPS (and other nutritional scores) in the context of ICD management in patients with HFrEF.

🔖

Bu Makaleye Atıf Yap

Könte, H. C., Alyan, Ö., Aras, D. (2026). Naples prognostic score, Prognostic Nutritional Index, and CONUT score in predicting implantable cardioverter-defibrillator therapy outcomes in HFrEF. Anatolian Current Medical Journal, Volume: 8 Issue: 2. https://doi.org/10.38053/acmj.1852985

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (32)

  1. Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7-11. doi:10.15420/cfr.2016:25:2
  2. Nijst, P., 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Anesteziol a Intenziv Med. 2022;33(1):60-62.
  3. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(14):e91-e220. doi:10.1016/j.jacc.2017.10.054
  4. Theuns DAMJ, Schaer BA, Caliskan K, et al. Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillators. Int J Cardiol. 2021;330:73-79. doi:10. 1016/j.ijcard.2021.01.011
  5. Driggin E, Cohen LP, Gallagher D, et al. Nutrition assessment and dietary interventions in heart failure: jacc review topic of the week. J Am Coll Cardiol. 2022;79(16):1623-1635. doi:10.1016/j.jacc.2022.02.025
  6. Alagiakrishnan K, Banach M, Ahmed A, Aronow WS. Complex relationship of obesity and obesity paradox in heart failure-higher risk of developing heart failure and better outcomes in established heart failure. Ann Med. 2016;48(8):603-613. doi:10.1080/07853890.2016.1197415
  7. Ikeya Y, Saito Y, Nakai T, et al. Prognostic importance of the Controlling Nutritional Status (CONUT) score in patients undergoing cardiac resynchronisation therapy. Open Heart. 2021;8(2):e001740. doi:10.1136/openhrt-2021-001740
  8. Kawakubo Y, Shiraishi Y, Kohsaka S, et al. Potential association with malnutrition and allocation of combination medical therapies in hospitalized heart failure patients with reduced ejection fraction. Sci Rep. 2022;12(1):8318. doi:10.1038/s41598-022-12357-4
  9. Yalcinkaya R, Öz FN, Durmuş SY, et al. Is there a role for laboratory parameters in predicting coronary artery involvement in kawasaki disease?. Spielen Laborparameter bei der Vorhersage einer Beteiligung der Koronararterien beim Kawasaki-Syndrom eine Rolle?. Klin Padiatr. 2022;234(6):382-387. doi:10.1055/a-1816-6754
  10. Çinier G, Hayıroğlu Mİ, Pay L, et al. Prognostic nutritional index as the predictor of long-term mortality among HFrEF patients with ICD. Pacing Clin Electrophysiol. 2021;44(3):490-496. doi:10.1111/pace.14170
  11. Yakut I, Kanal Y, Aksoy A, et al. Nutritional status is associated with mortality but not appropriate discharge of implantable cardioverter defibrillators in patients with heart failure. Diagnostics (Basel). 2025; 15(5):610. doi:10.3390/diagnostics15050610
  12. Lu H, Claggett BL, Minamisawa M, et al. Prognostic significance of nutritional scores in patients with heart failure: insights from the PARAGON-HF trial. J Am Heart Assoc. 2025;14(9):e038872. doi:10.1161/JAHA.124.038872
  13. Vandenberk B, Floré V, Röver C, et al. Repeating noninvasive risk stratification improves prediction of outcome in ICD patients. Ann Noninvasive Electrocardiol. 2020;25(6):e12794. doi:10.1111/anec.12794
  14. Galizia G, Lieto E, Auricchio A, et al. Naples prognostic score, based on nutritional and inflammatory status, is an independent predictor of long-term outcome in patients undergoing surgery for colorectal cancer. Dis Colon Rectum. 2017;60(12):1273-1284. doi:10.1097/DCR.000000000 0000961
  15. Aydın SŞ, Aydemir S, Özmen M, et al. The importance of Naples prognostic score in predicting long-term mortality in heart failure patients. Ann Med. 2025;57(1):2442536. doi:10.1080/07853890.2024.2442536
  16. Kılıç O, Suygun H, Mustu M, et al. Is the Naples prognostic score useful for predicting heart failure mortality. Kardiologiia. 2023;63(3):61-65. doi:10.18087/cardio.2023.3.n2328
  17. Erdogan A, Genc O, Ozkan E, et al. Impact of Naples prognostic score at admission on in-hospital and follow-up outcomes among patients with ST-segment elevation myocardial infarction. Angiology. 2023;74(10): 970-980. doi:10.1177/00033197231151559
  18. Dervis E, Hakgor A, Goksu MM, et al. Association of the Naples prognostic score with long-term adverse events in chronic limb-threatening ischemia after below-the-knee endovascular revascularization. Diagnostics (Basel). 2024;14(23):2627. doi:10.3390/diagnostics14232627
  19. Gitmez M, Güzel T, Kis M, et al. The performance of the Naples prognostic score in predicting one-year mortality and major adverse cardiovascular events after transcatheter aortic valve implantation in patients with severe aortic stenosis. Kardiol Pol. 2025;83(3):287-294. doi: 10.33963/v.phj.103230
  20. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008; 359(10):1009-1017. doi:10.1056/NEJMoa071098
  21. Tatar S, Kan H, Sahin AT, Sertdemir AL, İcli A, Akilli H. Does the Naples prognostic score predict long-term mortality in patients with advanced-stage heart failure?. Acta Cardiol Sin. 2025;41(2):210-218. doi: 10.6515/ACS.202503_41(2).20241023A
  22. Larsen GK, Evans J, Lambert WE, Chen Y, Raitt MH. Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm. 2011;8(12):1881-1886. doi:10.1016/j.hrthm.2011.07.036
  23. Cheng YL, Sung SH, Cheng HM, et al. Prognostic nutritional index and the risk of mortality in patients with acute heart failure. J Am Heart Assoc. 2017;6(6):e004876. doi:10.1161/JAHA.116.004876
  24. Fărcaș DA, Cerghizan A, Maior R, Mîndrilă AC, Tarcea M. CONUT score as a predictor of mortality risk in acute and chronic heart failure: a meta-analytic review. Nutrients. 2025;17(10):1736. doi:10.3390/nu17101736
  25. Ignacio de Ulíbarri J, González-Madroño A, de Villar NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp. 2005;20(1):38-45.
  26. Onodera T, Goseki N, Kosaki G. Nihon Geka Gakkai Zasshi. 1984;85(9): 1001-1005.
  27. Kato T, Yaku H, Morimoto T, et al. Association with controlling nutritional status (CONUT) score and in-hospital mortality and infection in acute heart failure. Sci Rep. 2020;10(1):3320. doi:10.1038/s41598-020-60404-9
  28. Schrage B, Lund LH, Benson L, et al. Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality. Eur J Heart Fail. 2022;24(7):1212-1222. doi:10. 1002/ejhf.2530
  29. Verstraelen TE, van Barreveld M, van Dessel PHFM, et al. Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death. Europace. 2021;23(6):887-897. doi:10.1093/europace/euab012
  30. Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013;1(2):93-102. doi:10.1016/j.jchf.2013.01.006
  31. Sharma A, Lavie CJ, Borer JS, et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015;115(10):1428-1434. doi:10.1016/j.amjcard.2015.02.024
  32. Wilson DG, Sharma-Oates A, Sheldon J, et al. Predictors of death without prior appropriate therapy in ICD recipients: the comorbidities, frailty and functional status (COMFFORT study). Open Heart. 2024; 11(2):e002574. doi:10.1136/openhrt-2023-002574